Physician profile
Philip Broshears
NPI 1215138920
$9,107.72
in general payments reported to CMS, 2019-2025
54 companies · $1,697 in 2025
The $1,697 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $1,004 · 2021: $1,928 · 2022: $717 · 2023: $1,436 · 2024: $1,754 · 2025: $1,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,886.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,333.99 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,095.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $936.41 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $697.82 | 2019-2025 | Repatha, Otezla, Evenity |
| Merck Sharp & Dohme LLC | $483.48 | 2019-2024 | Verquvo, Belsomra, Gardasil 9 |
| Astrazeneca Pharmaceuticals Lp | $423.23 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $338.54 | 2023-2025 | Rexulti, Abilify Maintena |
| Corium, LLC | $328.36 | 2023-2025 | Azstarys |
| Pfizer INC. | $302.87 | 2019-2025 | |
| Lilly USA, LLC | $280.76 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $280.17 | 2019-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $275.22 | 2019-2025 | Jardiance |
| Allergan, INC. | $240.79 | 2019-2021 | |
| Astellas Pharma US INC | $212.77 | 2020-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $201.61 | 2019-2025 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $149.58 | 2024-2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $124.36 | 2021 | |
| Mylan Specialty L.P. | $105.12 | 2023-2024 | Yupelri |
| Amarin Pharma, INC. | $98.46 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.24 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $75.09 | 2019-2022 | |
| Eisai INC. | $66.62 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $65.51 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $56.60 | 2021-2025 | Camzyos, Eliquis |
| Viatris Specialty LLC | $55.66 | 2025 | Yupelri |
| Biogen, INC. | $49.56 | 2021 | |
| Xeris Pharmaceuticals, INC. | $47.67 | 2022-2023 | Gvoke Hypopen |
| Dexcom, INC. | $45.49 | 2021-2025 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $36.55 | 2024-2025 | Auvelity |
| Lundbeck LLC | $36.19 | 2022-2024 | Vyepti |
| Boston Scientific Corporation | $35.06 | 2025 | Watchman Flx |
| Inspire Medical Systems, INC. | $34.30 | 2024-2025 | Inspire |
| Exact Sciences Corporation | $34.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $33.90 | 2023-2025 | Gemtesa |
| Horizon Therapeutics Plc | $31.90 | 2020-2021 | |
| Inari Medical, INC. | $31.29 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pulmonx Corporation | $30.08 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Daiichi Sankyo INC. | $28.03 | 2023 | Injectafer |
| Phathom Pharmaceuticals, INC. | $27.53 | 2025 | Voquezna |
| Cmp Pharma, INC. | $25.65 | 2022 | |
| Shire North American Group INC | $25.12 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.94 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $23.00 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $21.96 | 2025 | Fanapt |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.77 | 2022 | |
| Paratek Pharmaceuticals, INC. | $20.66 | 2020 | |
| Abbott Laboratories | $19.77 | 2022 | |
| Lifescan, INC. | $18.82 | 2023 | |
| Hologic Sales and Service, LLC | $18.11 | 2024 | Aptima |
| Ultragenyx Pharmaceutical INC. | $17.82 | 2020 | |
| Organon LLC | $16.85 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $15.32 | 2024 | |
| Esperion Therapeutics, INC. | $15.14 | 2020 | |
| Ironshore Pharmaceuticals INC. | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Broshears listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.